[1]
SHAH, S.J. et al. 2022. ROLE OF TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE COVID-19 PNEUMONIA. Asian Journal of Pharmaceutical and Clinical Research. 15, 11 (Nov. 2022), 121–125. DOI:https://doi.org/10.22159/ajpcr.2022.v15i11.45609.